Goyal undertakes aerial survey of upcoming Dighi Port Industrial Area (See 'Corp Brief') India-Japan partnership rooted in brotherhood: Goyal (See 'Corp Brief') IBC - High Court shouldn't have prohibited insolvency proceedings initiated against personal guarantor, by holding that guarantor's liability has been waived: SC (See 'Legal Desk') Ministry of Defence signs Rs 697 Cr contracts with ACE Ltd & JCB India Ltd (See 'Corp Brief') PMLA - Prolonged incarceration under draconian statutes, particularly when trial is unlikely to conclude within reasonable timeframe, could violate Article 21, which guarantees right to speedy trial: SC (See 'Legal Desk') Govt to establish 'Ambedkar Chair' & Student Facilities at Mumbai Univ (See 'Corp Brief') A&C - Allegations of fraud/ corruption must be substantiated with prima facie evidence; mere erroneous decision/ exceeding of scope of dispute by Arbitrator doesn't warrant unconditional stay of arbitral award: HC (See 'Legal Desk') 15,860 consumer grievances registered in Arunachal Pradesh in 2024 (See 'Corp Brief') A&C - Courts in Ranchi shall have jurisdiction to entertain arbitration proceedings since both parties has intention that proceeding will be conducted at Ranchi: HC (See 'Legal Desk') TRIFED enters into MOUs with Reliance Retail, HCL & Torajamelo Indonesia (See 'Corp Brief') A&C - Arbitration award being primarily based on consent cannot be held to be patently illegal or in conflict with public policy of India: HC (See 'Legal Desk') STPI launches new incubation facility at Salt Lake (See 'Corp Brief') SEBI Act, 1992 -Trades executed by Noticee are not genuine trades and created appearance of artificial trading volumes: SEBI (See 'Legal Desk') National Commission for Scheduled Tribes celebrates 22nd Foundation Day (See 'Corp Brief') IPR - If defendants caused irreparable harm to plaintiff and eroded value of its copyrights by taking away significant revenues through their unauthorized platforms, such case calls for permanent injunction: HC (See 'Legal Desk') MeitY introduces Digital Brand Identity Manual to harmonize govt's Digital presence (See 'Corp Brief') Ministry of Coal organizes Roadshow in Kolkata (See 'Corp Brief') IPR - If continuation of registration of trademark in name of respondent in Register of Trade Marks is in contravention of Sections 9, 11 & 18 of Trade Marks Act, same is liable to be cancelled: HC (See 'Legal Desk') TRIFED signs MoUs with Meesho, IFCA & Mahatma Gandhi Institute (See 'Corp Brief') Patents Act - Merely because life of patent has expired, does not mean that petition becomes infructuous: HC (See 'Legal Desk') Labour Secy leads Indian delegation at First G20 Employment Working Group (See 'Corp Brief') PMLA - Termination of lease and resumption of land may not be legal proceedings, but can be entertained as claim against company in liquidation: HC (See 'Legal Desk') TRIFED and Tea Trunk sign MoU to bolster Tribal economy (See 'Corp Brief') PMLA - Bail application can be dismissed when applicant has been unable to put forth any propositions that are sufficient for grant of bail: HC (See 'Legal Desk') CCI nod for amalgamations of Chaitanya India & Svatantra Holdings into Svatantra Microfin (See 'Corp Brief') IBC - Classification of borrower's account as fraud has effect of preventing borrower from accessing institutional finance for purpose of business: HC (See 'Legal Desk') India to be Partner Country of the Year at BIOFACH 2026 (See 'Corp Brief') Trade Marks Act - Name of Shri Ratan Tata is a well-known personal name/mark, which can be protected from any unauthorised use: HC (See 'Legal Desk') CCI okays acquisition of equity in Blackwater Coal Mine by NS Blackwater (See 'Corp Brief') PMLA - Once ED has demonstrated foundational facts, onus shifts to accused to rebut presumption that proceeds of crime were not involved in money laundering: HC (See 'Legal Desk') DoT, ITU sign LoI to collaborate on PhD Research (See 'Corp Brief') A&C - Claimant can't be non-suited on ground that they waived or abandoned their rights to seek reimbursement for costs suffered to make supplies: HC (See 'Legal Desk') Ministry of Steel organizes Chintan Shivir in Bengaluru (See 'Corp Brief') IPR - If plaintiff has sole and exclusive rights in and over trademark, defendants causing infringement of its trademark, copyright and artistic work, needs to be restrained: HC (See 'Legal Desk') Mahakumbh 2025: CRPF Personnel prepared to handle every Emergency Situation (See 'Corp Brief') Arbitration Act - If plaintiffs elected remedy under some other Act then plaintiffs cannot file suit for recovery of money and parties cannot be referred to arbitration : HC (See 'Legal Desk') India's 4th-Generation Deep-Ocean Submersible successfully completes testing (See 'Corp Brief') PMLA - Trial under Prevention of Money Laundering Act is different from trial of predicate offence and thus accused can't seek for simultaneous or joint trial even if both are pending before same court: HC (See 'Legal Desk') HMoST highlights Zero waste technologies in silk value chain (See 'Corp Brief') A&C - Sec 2(1)(f) which defined International Commercial Arbitration is non derogable provision, and its applicability can't be excluded even by mutual consent of parties: HC (See 'Legal Desk') IBC - Though maximum timeline prescribed u/s 12(3) of 330 days is directory & not mandatory, extension beyond 330 days is permissible only in 'exceptional circumstances', if short time is required to complete CIRP: NCLAT (See 'Legal Desk') Breathing Threads : Fashion Show at Bharat Tex 2025 (See 'Corp Brief') Govt announces opening of Nominations for PM's Yoga Awards 2025 (See 'Corp Brief') PMLA - Company who undergo successful resolution process u/s 31 of IBC, shall not be prosecuted for offences committed prior to commencement of CIRP: HC (See 'Legal Desk') Tripura's Bamboo Industry set grow with Central Support: MoS (See 'Corp Brief') Nadda inaugurates 2nd AIIMS Oncology Conclave 2025 (See 'Corp Brief') SEBI Act - Trade pattern shows that instructions are given with regard to buy and sell orders, based on prior knowledge: SAT (See 'Legal Desk') DPIIT Secy chairs Review of Mega Infra Projects of Gujarat and Rajasthan (See 'Corp Brief') IBC - After initiation of moratorium u/s 14(1), no assessment proceedings can be continued by EPFO: NCLAT (See 'Legal Desk') SECL approves CSR Projects worth Rs. 170 Cr (See 'Corp Brief') Competition Act - TTFI and its affiliate bodies hold dominant position in relevant markets for organisation of table tennis leagues/events; Cease-and-desist order passed imposing monetary penalty: CCI (See 'Legal Desk')

Print

Nadda inaugurates 2nd AIIMS Oncology Conclave 2025

Published: Feb 17, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 17, 2025: UNION Minister of Health & Family Welfare, Jagat Prakash Nadda, inaugurated the 2nd AIIMS Oncology Conclave 2025 at the National Cancer Institute (NCI) of AIIMS, Jhajjar campus, today. National Cancer Institute (NCI) of AIIMS, Jhajjar campus is one of the largest public-funded healthcare projects in India, dedicated to providing innovative cancer care and research capabilities. The AIIMS Oncology Conclave aimed to bring together leading experts in oncology across all the Institute of National Importance (INIs) of India, to discuss advancements in cancer care, treatment methodologies, and ongoing research initiatives. With a focus on breast cancers and head and neck cancers, the conclave emphasized collaborative efforts in prevention and management of such cancers.

Addressing the gathering, Nadda showed his elation over the growth and progress of the NCI since its inauguration in 2019, and stated that "the institute has matured into a world-class healthcare provider in a short span of 6 year and over time, it has evolved into a referral centre offering multidisciplinary care and providing better and patient-centric care". He appreciated the dedication of doctors, health workers and administration of the institute to make the progress happen.

Nadda also went for a special visit to the newly built Nuclear Medicine Targeted Treatment Ward and the Bone Marrow Transplant (BMT) Unit at the NCI aimed at improving patient outcomes through state-of-the-art treatment options specifically for thyroid cancers and hematolymphoid cancers, respectively. Underlining the importance of these developments, Nadda stated that "these new facilities will provide state-of-the-art care to many cancer patients in this region". He added that "under the dynamic leadership of Prime Minister Narendra Modi, the narrative is changing regarding the Indian healthcare system where Bone marrow Transplant is possible in institutes like NCI." He admired the high-quality precision and high-quality services of the Nuclear Medicine Targeted Treatment Ward and underlined that "these facilities are the hardware while the faculty members and doctors are the software of the developing robust healthcare system."

Nadda further stated that "Cancer is a daunting diagnosis that brings fear-not just of the illness, but of the future, of livelihood, of losing loved ones, and the inevitable economic and emotional strain". He also visited and appreciated the Vishram Sadan at the NCI, developed by the Infosys Foundation, provides essential accommodation for patients' attendants in a cost-effective way, enhancing support for families during challenging times. It also provides psychological and educational support to the needy, setting a benchmark for others.

Appreciating the innovation at the Institute, Nadda stated that "the Institute is collaborating with startups, engaging Ph. D. students and involving scientists from AIIMS in research that will have real-world applications, not just for the market, but for society as a whole. As an "Incubator," the Centre for Medical Innovations and Entrepreneurship (CMIE) is responsible to handhold and support indigenous innovations in the healthcare sector, which is tremendous. By enabling Indian start-ups to leverage the mentorship and guidance of AIIMS faculty and scientists, and by giving them access to advanced laboratory equipment and resources at AIIMS at nominal payment, CMIE is fostering a culture of innovation." He also appreciated the boot camps which fostered the budding start-ups and entrepreneurs to ideate and manufacture healthcare solutions in India, for India.

Highlighting the Government of India's efforts Nadda stated that "to prevent and control cancer, improve overall cancer care outcomes and ensure that every citizen, regardless of their location, has access to the care they need, the Government has been working on provision of Cancer care at primary health care level in the form of prevention and screening, and at the tertiary and secondary level in the form of diagnostics and treatment and palliative care."

He underlined that "the Government has introduced screening for individuals aged 30 years and above under NHM at Ayushman Arogya Mandirs and over 26 crore people have been screened for oral cancer, 14 crore for breast cancer, and 9 crore for cervical cancer at Ayushman Aarogya Mandirs." He Also added that "to enhance the facilities for tertiary level care of cancer, over the last few years over 3000 crore Rupees have been approved for the period 2014-15 to 2025-26 for 19 State Cancer Institutes (SCIs) and 20 Tertiary Cancer Care Centres (TCCCs). Moreover, Cancer treatment facilities have been approved in all 22 new AIIMS with diagnostic, medical and surgical facilities."

He also emphasized that "to make cancer treatment available to the poor and the vulnerable, under AB PM-JAY, cancer-related treatment is provided for Medical, Surgical, Radiation and Palliative Oncology across 219 packages. Since the inception of AB PM-JAY, approximately 68.43 Lakh hospital admissions amounting to Rs. 13160.75 Crores have been authorized for cancer related packages under the scheme."

Citing a recent LANCET study, he underlined that "timely cancer treatment initiation has improved significantly because of the Ayushman Bharat Jan Aarogya Yojna. Patients enrolled under AB-PMJAY saw 90% rise in access to cancer treatment within 30 days." He also highlighted that "through the 217 AMRIT Pharmacies spread across the country, 5200 drugs for various diseases including cancer are made available at an affordable rate.   Altogether, 289 oncology drugs are given at a significant discount of upto 50% of market rates. As a result, so far a total of Rs. 6567 Crore. have been saved for 5.8 crore beneficiaries based on discount offered."

Nadda further added that "We have plans to establish Day Care Cancer Centres (DCCCs) in all district hospitals over the next three years with 200 this year itself. This initiative aims to bring essential cancer services closer to home, particularly for those in underserved rural areas."

He added that "It is encouraging to see this institution engaging with other AIIMS and Institutes of National Importance (INIs) across the country to encourage research and innovation. The AIIMS Oncology Conclave 2025 is another step in this direction. This conclave has been designed to bring together leading experts, researchers and clinicians from all AIIMS and INIs to collaborate on the latest advancements in cancer research, treatment strategies, and prevention".

Nadda emphasized on the significant responsibility being carried by the doctors and other stakeholders in continued learning, sharing, and progressing to ensure healthcare to the patients and stated that "Coming together is a crucial first step towards advancing in critical areas like cancer care. I hope this initiative grows into a powerful collaboration where the National Cancer Institute can support and help other institutions develop side by side."

He highlighted that "the cancer incidence in India is rising. We are now seeing 1.45 million new cancer patients every year. As the complexity of cancer treatment continues to grow, it's not just about providing the best treatment-it's about making that treatment available locally. Patients should not have to travel long distances for the care they need. We need to develop advanced treatment capabilities at the local and regional levels, and it is your responsibility to make this happen."

He also announced that "the Government of India has approved creation of 720 additional posts for NCI Jhajjar. These posts include: Faculty positions, SRs/JRs, Scientists, Nurses, Technicians and Administrative posts and added that "with creation of these additional posts, NCI will rise to greater heights."

Nadda also felicitated the social activists and organizations who played quintessential roles in ensuring replacement-donation free transfusion services to patients being treated at NCI in the last 5 years. Besides, he launched an education short film as a part of the tobacco cessation campaign of NCI's preventive oncology unit.

The Conclave with the theme "Discuss Practice and Research Avenues in Breast Cancer" aimed to foster innovation, share knowledge, and build partnerships to accelerate progress in the fight against cancer.This type of initiative, which pools the knowledge and resources of multiple institutions, has the potential to improve cancer research and treatment in India. The model developed by NCI could serve as a template for other AIIMS and INIs, allowing for a more coordinated, nationwide effort to enhance healthcare innovation.

The Conclave featured keynote speeches from renowned oncologists, break-out discussions, designed to address the pressing challenges faced in breast cancers and head and neck cancers.

Dr. M. Srinivas, Director, AIIMS, New Delhi, Dr. Alok Thakar, Head, National Cancer Institute, Jhajjar, Dr. K.K. Verma, Dean (Academics), AIIMS, Dr. Nikhil Tandon, Dean (Research), AIIMS, faculty Members of NCI, medical professionals, researchers, and healthcare policymakers of all AIIMS from across the country, PGI, Chandigarh and JIPMER, Puducherry, scientists, entrepreneurs, innovators were also present at the occasion.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
taxindiaonline
A Taxongo Website. Copyright © 2016-2022 tiolcorplaws.com All rights reserved.